Announcement of launch, break or close-out of marketing of a medicinal product

The database includes reports since 31st December 2007, date of effect of the Act No 378/2007 Coll., stipulating the obligation of marketing authorisation holders to report launch, suspension or withdrawal from the market of a medicinal product to SÚKL

Search

 

   

   

Number of records: 21
SÚKL code Name of medicinal product Supplement of name Type of announcement Effective date Alternate medicines 1)
Estimated renewal date Reason for interruption/cessation of marketing
0203002 ADVANTAN MASTNÝ KRÉM 1MG/G CRM 1X15G Cessation of marketing 03.08.2018 0224718, 0224725
0125114 ANOPYRIN 100MG TBL NOB 60(3X20) Cessation of marketing 02.08.2018 0207931, 0230511, 0230514, 0235897
Transfer of marketing authorisation
0067408 INDOBENE 10MG/G GEL 50G Cessation of marketing 01.08.2018 Jiná nesteroidní protizánětlivá léčiva k lokální aplikaci
0058408 NASOBEC 50MCG/DÁV NAS SPR SUS 1X200DÁV Cessation of marketing 01.08.2018 0102421, 0102423
0128530 NEOTIGASON 10MG CPS DUR 30 Cessation of marketing 01.08.2018 Lék není nahraditelný
0076403 SORBIMON 40MG TBL NOB 20 Cessation of marketing 01.08.2018 0023306, 0076404, 0076405, 0096188, 0096191
0183387 REGISHA 0,15MG/0,02MG TBL NOB 1X21 Cessation of marketing 31.07.2018 0132564, 0132742, 0132940, 0144051, 0180472, 0183388, 0192095, 0195676
0015266 CAPD/DPCA 17 PRN SOL 4X2000ML STAY SAFE Cessation of marketing 31.07.2018 Lék se stejnými indikacemi (např. CAPD/DPCA 2, Balance a další)
0162142 PARALEN 500 500MG TBL NOB 24 Cessation of marketing 31.07.2018 0013622, 0013623, 0162441, 0162443, 0207820, 0220291
0180992 PARALEN GRIP HORKÝ NÁPOJ CITRÓN 650MG/10MG POR GRA SUS 12 Cessation of marketing 31.07.2018 Lék se stejnými indikacemi
0043197 CERAZETTE 0,075MG TBL FLM 3X28 Cessation of marketing 31.07.2018 0132733, 0132792, 0132801, 0132847, 0214402, 0214403
0125002 ESMERON 10MG/ML INJ/INF SOL 10X5ML Cessation of marketing 31.07.2018 0124418
0002785 FUROSEMID - SLOVAKOFARMA FORTE 250MG TBL NOB 10 Cessation of marketing 30.07.2018 0207941
0214922 LIPANTHYL NT 145MG TBL FLM 90 Cessation of marketing 30.07.2018 0225959
0025273 DOSTINEX 0,5MG TBL NOB 8 I Cessation of marketing 25.07.2018 0132897, 0207273
0209039 ENTRESTO 49MG/51MG TBL FLM 28 Cessation of marketing 25.07.2018
vzorky pro lékaře
0209476 ENTRESTO 97MG/103MG TBL FLM 14 Cessation of marketing 25.07.2018 0209043
Vzorky pro lékaře
0006247 LUNAFEM 0,075MG/0,02MG TBL OBD 3X21 I Cessation of marketing 24.07.2018 0115716, 0132681, 0132696, 0132794, 0132845, 0132855, 0132894, 0132945, 0148064, 0148065, 0192768, 0192769, 0203566, 0212515, 0212516, 0213473, 0213474, 0220207, 0224659, 0097557
0066196 YADINE 3MG/0,03MG TBL FLM 3X21 Cessation of marketing 24.07.2018 0132740, 0132793, 0132813, 0132858, 0132982, 0132998, 0152106, 0163982, 0169102, 0180922, 0184708, 0196868, 0196870, 0198738, 0198739, 0208132, 0221057, 0221065
0139555 OXYKODON MYLAN 10MG TBL PRO 30X1 Cessation of marketing 24.07.2018 0011094, 0129790, 0139565, 0180349, 0223277

Page: 1 2  ››

1) The review shows only medicinal products with active incidence on the Czech market (based on regular reports of supplies of distributed human medicinal products in the previous quarter).

Medicinal products reimbursed from health insurance are marked in color.
Last database update: 7. July 2020 v 02:10